Bruno Francesco, Laganà Valentina, Pistininzi Rebecca, Tarantino Francesca, Martin Leslie, Servidio Rocco
Regional Neurogenetic Centre (CRN), Department of Primary Care, ASP Catanzaro, Viale A. Perugini, 88046 Lamezia Terme, CZ Italy.
Association for Neurogenetic Research (ARN), Lamezia Terme, CZ Italy.
Curr Psychol. 2022 May 27:1-11. doi: 10.1007/s12144-022-03209-5.
Despite the massive volume of scientific evidence on the benefits of immunisation, vaccine hesitancy is still a global health threat and represents an obstacle to controlling the spread of viruses such as SARS-CoV-2 and its associated COVID-19. Thus, the present study aimed to adapt and validate an Italian version of the Vaccination Attitudes Examination (VAX) scale. The Italian version of the scale (VAX-I), along with validation measures (general health perceptions, perceived sensitivity to medicines, intention to get the flu vaccine, and trust in health authorities) were administered to a sample of 534 Italian participants aged 18 to 87 ( = 32.41, = 15.35). The original version of the VAX scale was translated into Italian using a back-translation method. The parallel and confirmatory factor analyses showed that the scale's four-factor structure fits the data well, as in the original version. Reliability coefficients indicated that the VAX-I scale showed good internal consistency and measurement invariance results demonstrated that the VAX-I scale is stable across gender. Construct validity was supported by the significant negative correlation with general health perceptions, intentions to get the flu vaccine, and trust in health authorities, and the weak but significant and positive correlation with perceived sensitivity to medicines. Overall, the VAX-I scale appears to be a valid instrument to assess vaccine hesitancy in the Italian context.
The online version contains supplementary material available at 10.1007/s12144-022-03209-5.
尽管有大量关于免疫接种益处的科学证据,但疫苗犹豫仍然是全球健康威胁,也是控制SARS-CoV-2等病毒及其相关的COVID-19传播的障碍。因此,本研究旨在改编并验证意大利语版的疫苗接种态度调查问卷(VAX)量表。该量表的意大利语版(VAX-I)以及验证指标(一般健康认知、对药物的感知敏感性、接种流感疫苗的意愿以及对卫生当局的信任)被施用于534名年龄在18至87岁的意大利参与者样本(平均年龄=32.41岁,标准差=15.35岁)。VAX量表的原始版本采用回译法翻译成意大利语。平行和验证性因素分析表明,该量表的四因素结构与原始版本一样,与数据拟合良好。信度系数表明,VAX-I量表显示出良好的内部一致性,测量不变性结果表明VAX-I量表在不同性别间具有稳定性。与一般健康认知、接种流感疫苗的意愿以及对卫生当局的信任呈显著负相关,与对药物的感知敏感性呈微弱但显著的正相关,支持了结构效度。总体而言,VAX-I量表似乎是评估意大利背景下疫苗犹豫情况的有效工具。
在线版本包含可在10.1007/s12144-022-03209-5获取的补充材料。